Skip to content

Guangdong Zhongsheng Pharmaceutical Co Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access
Guangdong Zhongsheng Pharmaceutical Co Ltd · E.2317.SHE · China
Use symbol E.2317.SHE in our API & Excel add-in to retrieve this data ↓
—
(—)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum —
Trend —
Bubble Risk LOW
Realised Volatility (20D) —

Guangdong Zhongsheng Pharmaceutical Co Ltd Price Chart

MacroFinance.ai

Guangdong Zhongsheng Pharmaceutical Co Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Guangdong Zhongsheng Pharmaceutical Co Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Guangdong Zhongsheng Pharmaceutical Co Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Guangdong Zhongsheng Pharmaceutical Co Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Guangdong Zhongsheng Pharmaceutical Co Ltd
P/E
91.88x
Stretched vs own history
QoQ −17.7%
YoY —
now 91.877454.34 low117.07 high
ⓘP/E As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
P/S
8.82x
Stretched vs own history
QoQ −11.8%
YoY −2.3%
now 8.81885.94 low10.49 high
ⓘP/S As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
P/B
4.55x
Mid-range vs own history
QoQ −18.1%
YoY −17.0%
now 4.55193.69 low6.04 high
ⓘP/B As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
EV/EBITDA
82.34x
Stretched vs own history
QoQ −20.6%
YoY +36.3%
now 82.34540.51 low108.99 high
ⓘEV/EBITDA As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
EV/Sales
8.41x
Stretched vs own history
QoQ −13.0%
YoY −3.7%
now 8.41085.55 low10.16 high
ⓘEV/Sales As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Earnings Yield
1.1%
Mid-range vs own history
QoQ +21.5%
YoY −221.9%
now 1.0884-1.23 low1.84 high
ⓘEarnings Yield As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Dividend Yield
0.9%
Weak vs own history
QoQ −40.0%
YoY —
now 0.91770.92 low1.87 high
ⓘDividend Yield As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Market Cap
$18.5B
Mid-range vs own history
QoQ −16.7%
YoY −16.1%
now 18536.983714,984 low25,107 high
ⓘMarket Cap As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Guangdong Zhongsheng Pharmaceutical Co Ltd
Net Debt
-$858M
Mid-range vs own history
QoQ +14.8%
YoY +19.5%
now -857.5502-985.4 low-717.41 high
ⓘNet Debt As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Net Debt / EBITDA
-3.99x
Low vs own history
QoQ +10.8%
YoY +97.1%
now -3.9942-3.99 low-2.03 high
ⓘNet Debt / EBITDA As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Current Ratio
4.35x
Mid-range vs own history
QoQ −10.5%
YoY +16.6%
now 4.35073.73 low4.86 high
ⓘCurrent Ratio As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Quick Ratio
3.80x
Mid-range vs own history
QoQ −10.5%
YoY +14.6%
now 3.79513.31 low4.24 high
ⓘQuick Ratio As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Interest Coverage
76.52x
Strong vs own history
QoQ −9.6%
YoY −277.8%
now 76.519-43.04 low142.11 high
ⓘInterest Coverage As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Debt / Equity
0.00x
Low vs own history
QoQ —
YoY −100.0%
now 00 low0.14 high
ⓘDebt / Equity As of 20 Nov 2026.
Guangdong Zhongsheng Pharmaceutical Co Ltd
Piotroski F-Score
6
Mid-range vs own history
QoQ 0.0%
YoY +100.0%
now 63 low6 high
ⓘPiotroski F-Score As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Guangdong Zhongsheng Pharmaceutical Co Ltd
Altman Z-Score
12.95
Strong vs own history
QoQ −22.3%
YoY −6.5%
now 12.949110.39 low17.41 high
ⓘAltman Z-Score As of 20 Nov 2026.See Guangdong Zhongsheng Pharmaceutical Co Ltd returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  12 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  14 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Guangdong Zhongsheng Pharmaceutical Co Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Guangdong Zhongsheng Pharmaceutical Co Ltd fundamentals: income statement, balance sheet & cash flow

Guangdong Zhongsheng Pharmaceutical Co Ltd reported revenue of 2.52bn CNY and net income of 275.8m CNY in FY2025, the year ended 31 December 2025 — revenue up 2.2% and net income up 192.2% on the prior year. Free cash flow was -11.0m CNY. These figures are as reported in the filings, not restated: 20 fiscal years and 73 quarters of history, back to December 2006.

Revenue (FY2025)
2.52bn CNY
+2.2%
Net income
275.8m CNY
+192.2%
Gross margin
56.12%
Free cash flow
-11.0m CNY
-110.0%
Guangdong Zhongsheng Pharmaceutical Co Ltd income statement, annual, as reported · CNY millions unless stated
CNY millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue2,522.72,467.42,610.62,676.22,429.1
Cost of revenue1,107.01,135.41,081.2941.6813.7
Gross profit1,415.71,332.01,529.41,734.61,615.3
Research & development91.0116.8127.4156.6136.7
Selling, general & admin.—1,495.21,103.31,203.71,166.0
Operating income320.6-280.0298.7374.3312.7
EBITDA426.4322.5465.1477.9462.4
Interest expense5.026.247.474.273.8
Pre-tax income296.6-335.9283.7368.3309.5
Income tax—38.133.853.034.8
Net income275.8-299.2263.3322.1277.6

Download Guangdong Zhongsheng Pharmaceutical Co Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.2317.SHE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 20 fiscal years and 73 quarters, the filing vintages behind each number and API access.
Create free account

Figures in CNY, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Guangdong Zhongsheng Pharmaceutical Co Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Guangdong Zhongsheng Pharmaceutical Co Ltd Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Guangdong Zhongsheng Pharmaceutical Co Ltd; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

About Guangdong Zhongsheng Pharmaceutical Co Ltd (China)

Guangdong Zhongsheng Pharmaceutical Co Ltd is a listed security in China. This page shows the latest price and daily change, a price chart, its factor exposures, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Guangdong Zhongsheng Pharmaceutical Co Ltd

Frequently asked questions

What is Guangdong Zhongsheng Pharmaceutical Co Ltd?
Guangdong Zhongsheng Pharmaceutical Co Ltd is a listed security in China. On MacroFinance its page shows the latest price and daily change, a price chart, its factor exposures, the trading strategies that hold it and free historical data.
What factors affect Guangdong Zhongsheng Pharmaceutical Co Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Guangdong Zhongsheng Pharmaceutical Co Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Guangdong Zhongsheng Pharmaceutical Co Ltd?
28 backtested tactical asset allocation strategies trade Guangdong Zhongsheng Pharmaceutical Co Ltd through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
Where can I download free Guangdong Zhongsheng Pharmaceutical Co Ltd historical data?
In the Free historical data section of this page: the last 10 years of Guangdong Zhongsheng Pharmaceutical Co Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Guangdong Zhongsheng Pharmaceutical Co Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Guangdong Zhongsheng Pharmaceutical Co Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.2317.SHE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2021.81
2026-11-1923.4
2026-11-1823.86
2026-11-1724.48
2026-11-1624.72
2026-11-1325.67
2026-11-1225.72
2026-11-1125.22
2026-11-1025.2
2026-11-0925.3
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers onradir, Leretevir, compound danshen, Cefixime Dispersible, Pyrazinamide, Ethamibutanol Hydrochloride, Ribavirin, loratadine, and isoniazid tablets; compound thromboplastin series, Zhong Sheng Wan series, and heat-clearing and dampness-removing granules products; NaoShuanTong, Cefadroxil, Rifampicin, and omeprazole enteric-coated capsules; carbocysteine, Ambroxol Hydrochloride, and Clomastine fumarate oral solutions; sucralfate oral suspension; reba pat film; and Azalastine Hydrochloride, Praprofen, Diquafosol Sodium, and Cyclosporine eye drops. It also focuses on the fields of respiratory antiviral, ophthalmology, cardiovascular and cerebrovascular endocrinology, anti-infection, digestion, and anti-allergy. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Dongguan, China.